Status:

NOT_YET_RECRUITING

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

Lead Sponsor:

Aalborg University Hospital

Collaborating Sponsors:

Novo Nordisk A/S

DexCom, Inc.

Conditions:

Type 2 Diabetes Treated With Insulin

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control)...

Detailed Description

The DiaTRUST trial is an open-label randomized controlled trial with a six-month trial period. The trial will be conducted at Steno Diabetes Center North Jutland. Patients with T2D on insulin therapy ...

Eligibility Criteria

Inclusion

  • Adults ≥ 18 years.
  • Diagnosis of T2D for at least 12 months prior to the day of screening.
  • Patients who are being treated with insulin or about to start insulin treatment (insulin naïve) willing to travel to trial site in North Denmark to attend in-person visits.
  • Have internet at home, have MitID, and willingness to use a smartphone and the other devices used in the trial
  • Signed informed consent.
  • Ability to understand and read Danish.

Exclusion

  • Pregnancy or breastfeeding.
  • Major surgery is planned during the trial period.
  • Cancer diagnosis within five years prior to inclusion.
  • Participation in other interventional trials.
  • Limited literacy affecting the use of trial devices.
  • Patient who has worn a CGM monitor less than 6 months prior to the trial.
  • Terms that, in the opinion of the sub-investigator or investigator, render the participant unfit to conduct the trial, including lack of understanding of the trial or lack of physical or cognitive ability to participate.
  • Patients treated with mixed insulin.

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT06185296

Start Date

May 1 2025

End Date

June 1 2026

Last Update

January 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Endocrinology

Aalborg, North Jutland, Denmark, 9000